GRANULES INDIA .

3 weeks ago

Granules India (GRANULES): Press Release

Press Release Granules India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility". Granules India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility".

Continue Reading

3 weeks ago

Granules India (GRANULES): Press Release

Press Release Granules India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility". Granules India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility".

Continue Reading

3 weeks ago

Granules India Volume Spike Prompts NSE Query, Company Responds

The NSE flagged unusual trading volume in Granules India, prompting the exchange to seek clarification. The company has submitted its response to the query.

Continue Reading

3 weeks ago

Granules India Q4 FY26 Earnings Call Transcript Now on BSE

Granules India has filed the transcript of its Q4 and full fiscal year 2026 earnings conference call with BSE. The document covers management discussion on quarterly and annual performance for the period ended March 31, 2026.

Continue Reading

3 weeks ago

Granules India Discloses Analyst Call Transcript on NSE

Granules India has disclosed to NSE that a transcript from its recent analyst or institutional investor interaction is now available.

Continue Reading

1 year ago

GRANULES INDIA . Q3 FY25 Results

GRANULES INDIA . Q3 FY25 Results

Continue Reading

1 year ago

GRANULES INDIA . Q2 FY25 Results

GRANULES INDIA . Q2 FY25 Results

Continue Reading